PDCD1 and neoplasm: Decreasing the acidity of the tumor microenvironment with lactate dehydrogenase inhibitors prior to the treatment of ICIs resulted in a 2.3-fold increase in T-cell infiltration in patients using PD-1 monoclonal antibody.